VCP Scanner
ScreenerTechnicalBreakoutsThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistPricing
ScreenerTechnical ScannerBreakoutsThemes
Earnings
WatchlistPricing
Ctrl K
CNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CNACNA Financial Corporation
$51.00$13.8B
Overview & Verdict
OverviewVisualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCNABalance Sheet

CNA Financial Corporation (CNA) Balance Sheet

30Y historyFree accessUpdated daily

Total assets grew to $69.9 billion in Q2 2026 from $59.5 billion in Q1 2024, with equity of $11.2 billion and a conservative debt-to-equity ratio of 0.27, though legacy LTC and social inflation risks warrant monitoring.

CNA Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Assets69.87B69.44B60.81B59.56B55.79B61.69B60.19B56.87B52.92B52.73B51.39B50.98B51.7B51.95B53.45B49.92B48.96B55.77B52.21B57.64B61.49B58.79B62.5B68.5B61.73B65.97B62.07B61.22B62.36B61.27B60.73B
Asset Growth %30.7%14.19%2.1%6.75%-9.55%2.48%5.85%7.46%0.36%2.6%0.81%-1.4%-0.47%-2.82%7.08%1.97%-12.22%6.83%-9.42%-6.26%4.6%-5.94%-8.76%10.97%-6.42%6.28%1.39%-1.83%1.78%0.88%1.39%
Total Investment Assets4M50.45B47.48B46.56B43.18B50.33B50.29B47.74B44.49B46.87B45.42B44.7B46.26B46.29B47.95B44.79B43.1B42.42B35.39B42.24B44.6B38.72B38.14B37.75B34.58B34.88B34.4B34.69B36.51B40.13B40.29B
Long-Term Investments187.67B46.74B47.48B46.56B43.18B50.33B50.29B47.74B44.49B46.87B45.42B44.7B46.26B46.29B47.95B44.79B43.1B42.42B35.39B42.24B44.6B38.15B37.65B36.74B33.95B34.24B33.79B34.21B36.08B35.25B34.43B
Short-Term Investments1.72B3.71B00000000000000000004.24B5.86B7.54B7.01B3.74B4.72B3.35B4.04B4.88B5.85B
Total Current Assets2.06B14.73B4.14B3.79B3.63B3.48B3.03B2.69B2.63B2.65B2.48B2.46B2.13B2.17B2.04B1.69B1.63B8.38B9.3B10.29B11.67B58.44B62.1B68.03B61.19B65.26B61.03B60.15B61.17B59.9B59.67B
Cash & Equivalents339M425M472M345M475M536M419M242M310M355M271M387M190M195M156M75M77M140M85M94M84M96M95M139M126M142M163M153M217M383M257.1M
Receivables35.98B10.6B3.67B3.44B3.16B2.94B2.61B2.45B2.32B2.29B2.21B2.08B1.94B1.98B1.88B1.61B1.56B8.24B9.21B10.2B11.59B14.07B17.54B2.69B15.51B3.83B15M2.21B251M18M133.8M
Other Current Assets-4.2B0000000000000000000019.63B25.42B41.37B38.55B60.77B56.13B54.43B56.66B54.62B53.43B
Goodwill & Intangibles3.57B1.13B222M224M144M215M217M147M146M148M145M231M237M155M267M139M141M141M141M142M142M146M162M162M174M265M317M328M368M620M417.7M
Goodwill147M148M145M146M144M148M148M147M146M148M145M150M152M155M154M123M0141M141M142M142M0000000000
Intangible Assets0986M77M78M067M69M000081M85M0113M16M141M0000146M162M162M174M265M317M328M368M620M417.7M
PP&E (Net)291M282M453M393M381M401M451M502M324M326M310M343M295M304M326M309M333M360M393M378M277M197M235M314M369M444M716M746M824M747M645.4M
Other Assets-47.31B5.98B7.29B7.32B7B6.61B5.52B5.15B4.75B2.18B2.08B2.22B1.76B2.06B1.71B1.79B2.4B2.7B3.02B2.53B2.8B-38.15B-37.65B-36.74B-33.95B-34.24B-33.79B-34.21B-36.08B-35.25B-34.43B
Total Liabilities58.69B57.82B50.3B49.67B47.25B48.88B47.49B44.65B41.7B40.48B39.42B39.22B38.91B39.27B41.12B38.41B37.41B44.58B44.87B47.05B51.33B49.55B53.02B59.3B52.07B57.38B52.2B52.09B53B52.96B53.67B
Total Debt2.97B2.97B3.21B3.25B3B3.03B3.11B3.05B2.68B2.86B2.71B2.56B2.56B2.56B2.57B2.61B2.65B2.3B2.06B2.16B2.16B1.69B2.26B1.9B2.29B2.57B2.73B2.88B3.16B2.9B2.76B
Net Debt2.63B2.55B2.74B2.9B2.53B2.49B2.69B2.81B2.37B2.5B2.44B2.17B2.37B2.37B2.41B2.53B2.57B2.16B1.97B2.06B2.07B1.59B2.16B1.76B2.17B2.42B2.57B2.73B2.94B2.51B2.51B
Long-Term Debt2.97B2.97B2.97B2.48B2.54B2.78B2.78B2.68B2.68B2.71B2.71B2.21B2.56B2.01B2.56B2.52B2.25B2.3B2.06B1.81B2.16B1.44B1.73B1.64B1.87B2.24B2.73B2.88B3.16B2.9B2.76B
Short-Term Debt0043M586M243M42M44M38M0150M0350M0549M13M83M400M00350M0252M531M263M420M329M00000
Total Current Liabilities3.8B38.37B000000000000000000048.4B51.51B57.91B50.46B55.03B49.69B49.4B50.04B50.06B50.91B
Accounts Payable0000000000000000000001.64B03.43B2.76B000000
Deferred Revenue3.8B7.63B7.35B6.93B6.37B5.76B5.12B4.58B4.18B4.03B3.76B3.67B3.59B3.72B3.61B3.25B3.2B3.27B3.41B3.6B3.78B00029M000000
Other Current Liabilities030.74B000000000000000000031.12B31.87B-3.44B-2.99B51.98B00000
Deferred Taxes001000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K0000000000
Other Liabilities45.42B12.34B42.23B42.05B39.56B40.88B39.77B37.43B35.43B37.35B36.14B36.63B35.52B36.52B37.49B35.1B34.48B41.83B42.33B44.39B48.02B000-34M329M-2.73B-2.88B-3.16B-2.9B-2.76B
Total Equity11.19B11.62B10.51B9.89B8.55B12.81B12.71B12.21B11.22B12.24B11.97B11.76B12.79B12.67B12.34B11.51B11.55B11.2B7.34B10.59B10.16B9.24B9.48B9.21B9.66B8.59B9.86B9.13B9.36B8.31B7.06B
Equity Growth %26.33%10.54%6.27%15.73%-33.27%0.8%4.03%8.9%-8.39%2.3%1.81%-8.12%0.95%2.75%7.17%-0.35%3.16%52.55%-30.67%4.18%9.96%-2.54%2.98%-4.65%12.41%-12.91%8%-2.44%12.66%17.69%4.81%
Shareholders Equity11.19B11.62B10.51B9.89B8.55B12.81B12.71B12.21B11.22B12.24B11.97B11.76B12.79B12.67B12.34B11.51B10.98B10.69B6.92B10.2B9.83B8.95B9.21B8.95B9.4B8.37B9.65B8.94B9.16B8.31B7.06B
Minority Interest0000000000000000570M506M420M385M335M291M275M256M256M224M217M195M204M00
Retained Earnings9.64B9.91B9.69B9.76B9.34B9.66B9.08B9.35B9.28B9.41B9.36B9.31B9.64B9.49B8.77B8.31B7.88B7.26B6.84B7.29B6.49B5.62B5.6B5.16B6.59B6.68B8.33B7.11B7.26B6.98B6.02B
Common Stock683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M683M645M645M565M565M565M464M464M464M155M154.6M
Accumulated OCI-1.22B-1.1B-1.99B-2.67B-3.6B320M803M51M-878M32M-173M-315M400M442M831M480M326M-325M-3.92B103M549M359M650M841M604M226M873M1.19B1.06B589M298.7M
Return on Equity (ROE)11.99%11.55%9.4%13.07%6.39%9.28%5.54%8.54%6.93%7.43%7.24%3.9%5.43%7.49%5.27%5.31%6.07%4.52%-3.34%8.2%11.42%2.82%4.55%-15.02%1.79%-17.39%12.44%-1.86%2.58%12.57%13.99%
Return on Assets (ROA)1.94%1.96%1.59%2.09%1.16%1.94%1.18%1.82%1.54%1.73%1.68%0.93%1.33%1.78%1.21%1.24%1.32%0.78%-0.54%1.43%1.84%0.44%0.65%-2.18%0.26%-2.51%1.92%-0.28%0.37%1.58%1.6%
Equity / Assets16.01%16.73%17.29%16.61%15.32%20.76%21.11%21.48%21.2%23.22%23.29%23.06%24.75%24.4%23.08%23.06%23.59%20.07%14.06%18.37%16.53%15.72%15.17%13.44%15.64%13.02%15.89%14.92%15.01%13.56%11.62%
Debt / Equity0.27x0.26x0.31x0.33x0.35x0.24x0.24x0.25x0.24x0.23x0.23x0.22x0.20x0.20x0.21x0.23x0.23x0.21x0.28x0.20x0.21x0.18x0.24x0.21x0.24x0.30x0.28x0.32x0.34x0.35x0.39x
Book Value per Share41.1742.6838.5536.3431.3746.9546.5844.8441.1645.0044.1543.4347.2846.9145.7242.6942.8641.6127.2438.9538.7436.1037.0440.5942.6642.7753.4548.0450.4144.7638.04
Tangible BV per Share40.6338.5137.7435.5230.8446.1745.7844.3040.6344.4543.6142.5746.4146.3344.7342.1842.3341.0826.7238.4338.2035.5336.4139.8741.8941.4551.7446.3248.4241.4235.79

Key Metrics

Growth RegimeStable
ProfitabilityStable
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Nuclear verdicts and reserve adequacy

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Expansion Amid Hard Market

Total assets grew to $69.9B in Q2 2026 from $59.5B in Q1 2024, as per reported figures, indicating steady balance sheet expansion driven by premium growth and retained earnings.

The sequential increase in total assets from $68.6B in Q1 2026 to $69.9B in Q2 2026, alongside a rise in equity from $10.9B to $11.2B, suggests ongoing capital generation. This growth appears consistent with the hard market conditions, where premium rate increases are boosting written premiums and, consequently, invested assets. However, the pace of expansion has moderated compared to the earlier period, reflecting a maturing pricing cycle.

Investment Portfolio Stability Supports Earnings

Investment portfolio remains stable at $1.0B, as reported, with no unrealized loss data available; however, the low combined ratio suggests investment income is providing a buffer, based on reported figures.

The reported investment portfolio value of $1.0B is unusually low relative to total assets, likely indicating a data limitation rather than actual portfolio size. Given the company's P&C focus, the investment portfolio is typically the largest asset, and the stable combined ratio around 88-90% implies that investment income is contributing positively to overall profitability. The absence of investment yield data limits deeper analysis, but the consistency in combined ratios suggests investment returns are stable.

Reserve Releases Bolster Underwriting Results

Loss ratio improved to 65.9% in Q2 2026 from 70.2% a year earlier, as per reported figures, suggesting favorable prior-year reserve development that may be flattering current earnings.

The year-over-year improvement in the loss ratio from 70.2% in Q2 2025 to 65.9% in Q2 2026, despite stable claims payments around $2.5B per quarter, indicates that reserve releases are contributing to underwriting profitability. This trend, also noted in the income statement analysis, suggests that past underwriting was conservative. However, investors should monitor whether such favorable development can persist, as social inflation and nuclear verdicts could necessitate adverse reserve adjustments in the future.

Equity Buffer Strengthens with Minimal Debt

Equity rose to $11.2B in Q2 2026 from $10.7B a year earlier, as reported, while debt-to-equity remains minimal at 0.26%, indicating a strong capital position.

The increase in equity, coupled with the extremely low financial leverage, suggests that CNA maintains a fortress-like balance sheet. This capital strength provides ample capacity for dividend payments, including special dividends, and potential strategic actions. The low debt levels also imply significant untapped borrowing capacity, which could be used to weather severe underwriting losses or fund opportunistic acquisitions, though management's conservative approach under Loews may prioritize capital preservation.

Claims-Paying Ability Supported by Stable Cash Flows

Claims payments have remained stable at approximately $2.5B per quarter over the past year, as per reported figures, while operating cash flow consistently exceeds net income, indicating robust liquidity.

The stability in claims payments, despite inflationary concerns, suggests that CNA's liquidity position is adequate to meet its obligations. The cash flow analysis indicates that operating cash flow has been consistently strong, with an OCF/NI ratio around 2.0, implying that earnings are well-backed by cash. This liquidity profile, combined with a diversified investment portfolio, supports the company's ability to pay claims even in adverse scenarios, though the lack of detailed cash and liquid asset data limits a more precise assessment.

Legacy LTC and Social Inflation Risks Loom

The Life & Group run-off segment and rising nuclear verdicts may pose hidden reserve risks, as per industry trends, potentially straining future balance sheet strength.

While the core P&C operations appear healthy, the legacy long-term care (LTC) liabilities in the Life & Group segment remain a potential source of adverse reserve development. Additionally, the increasing frequency of nuclear verdicts in casualty lines could require reserve strengthening, particularly in umbrella and general liability. These factors, combined with the lack of forward guidance, suggest that the current balance sheet strength may be tested in future periods, warranting close monitoring of reserve adequacy and loss cost trends.

CNA — Frequently Asked Questions

Quick answers to the most common questions about buying CNA stock.

What are the total assets of CNA Financial Corporation (CNA)?

As of 2025, CNA Financial Corporation (CNA) had total assets of $69.44B including $14.73B in current assets.

How much debt does CNA Financial Corporation (CNA) have?

CNA Financial Corporation (CNA) carries total debt of $2.97B, offset by $4.13B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of CNA Financial Corporation?

CNA Financial Corporation (CNA) has total shareholders' equity (book value) of $11.62B ($42.68 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is CNA Financial Corporation's current ratio and liquidity?

CNA Financial Corporation (CNA) reported a current ratio of 0.38x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.